(Hypertension. 1999;34:631-637.)
© 1999 American Heart Association, Inc.
Scientific Contributions |
From the Department of Medicine, Indiana University School of Medicine (W.T.A., L.J.B., L.Z., J.F.R., M.A.W., C.G., J.H.P.), and the VA Medical Center (M.A.W., C.G., J.H.P.), Indianapolis, Ind; and the Department of Internal Medicine, University of Iowa College of Medicine (P.M.S.), Iowa City, Iowa.
Correspondence to J. Howard Pratt, MD, 541 Clinical Dr, Indianapolis, IN 46202-5111. E-mail johpratt{at}iupui.edu
AbstractRenin and
aldosterone secretion is often lower in blacks than in
whites, characteristics that resemble a milder form of Liddle syndrome
in which a mutation in the amiloride-sensitive epithelial sodium
channel (ENaC) of the kidney results in enhanced resorption of sodium.
In the present study, we looked for evidence that the intrinsic
level of ENaC activity is indeed higher in blacks than in whites. In
overnight urine samples collected from young people (249 white and 181
black subjects, mean age 13.4 years), the urinary
aldosterone/potassium ratio, which is typically very low in
Liddle syndrome, was lower in blacks than in whites: 0.421±0.024
(mean±SE) versus 0.582±0.016 nmol/mmol (P<0.0001). In
addition, all but 1 of 5 molecular variants in ENaC were much more
common in blacks than in whites. G442V in the ß-subunit, present
in 16% of the blacks and in only 1 white, was associated with
parameters reflective of a greater Na retention and
potentially a higher ENaC activity: a lower plasma
aldosterone concentration (P=0.070), a lower
urinary aldosterone excretion rate
(P=0.052), a higher potassium excretion rate
(P=0.048), and a lower urinary
aldosterone/potassium ratio (P=0.027). In a
second cohort consisting of 126 black and 161 white normotensive
subjects and 232 black and 188 white hypertensive subjects, ßG442V
did not show a significant association with hypertension
(P=0.089). On the other hand, a variant that was twice
as common in whites,
T663A, was associated with being normotensive
both in blacks (P=0.018) and in whites
(P=0.034). Expression of either ßG442V or
T663A in
Xenopus oocytes did not result in a change in basal Na
current, consistent with the variants being in linkage
disequilibrium with alleles at active loci. In conclusion, several
lines of evidence are presented to suggest that ENaC activity
is higher in blacks than in whites, which could contribute to racial
differences in Na retention and the risk for hypertension.
Key Words: sodium channels aldosterone potassium hypertension, sodium-dependent race
This article has been cited by other articles:
![]() |
L. Mutesa, A. K. Azad, C. Verhaeghe, K. Segers, J.-F. Vanbellinghen, L. Ngendahayo, E. K. Rusingiza, P. R. Mutwa, S. Rulisa, L. Koulischer, et al. Genetic Analysis of Rwandan Patients With Cystic Fibrosis-Like Symptoms: Identification of Novel Cystic Fibrosis Transmembrane Conductance Regulator and Epithelial Sodium Channel Gene Variants Chest, May 1, 2009; 135(5): 1233 - 1242. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Bhalla and K. R. Hallows Mechanisms of ENaC Regulation and Clinical Implications J. Am. Soc. Nephrol., October 1, 2008; 19(10): 1845 - 1854. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. C. Rossier and L. Schild Epithelial Sodium Channel: Mendelian Versus Essential Hypertension Hypertension, October 1, 2008; 52(4): 595 - 600. [Full Text] [PDF] |
||||
![]() |
N. Gaukrodger, P. J. Avery, and B. Keavney Plasma potassium level is associated with common genetic variation in the {beta}-subunit of the epithelial sodium channel Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2008; 294(3): R1068 - R1072. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Yan, L. Spruce, M. M. Rosenblatt, T. R. Kleyman, and R. C. Rubenstein Intracellular trafficking of a polymorphism in the COOH terminus of the {alpha}-subunit of the human epithelial sodium channel is modulated by casein kinase 1 Am J Physiol Renal Physiol, September 1, 2007; 293(3): F868 - F876. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Tong, A. G. Menon, and J. D. Stockand Functional polymorphisms in the {alpha}-subunit of the human epithelial Na+ channel increase activity Am J Physiol Renal Physiol, April 1, 2006; 290(4): F821 - F827. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Yan, L. Suaud, T. R. Kleyman, and R. C. Rubenstein Differential modulation of a polymorphism in the COOH terminus of the {alpha}-subunit of the human epithelial sodium channel by protein kinase C{delta} Am J Physiol Renal Physiol, February 1, 2006; 290(2): F279 - F288. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. M. Snyder Minireview: Regulation of Epithelial Na+ Channel Trafficking Endocrinology, December 1, 2005; 146(12): 5079 - 5085. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. H. Pratt Central Role for ENaC in Development of Hypertension J. Am. Soc. Nephrol., November 1, 2005; 16(11): 3154 - 3159. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Saha, G. J. Eckert, W. T. Ambrosius, T.-Y. Chun, M. A. Wagner, Q. Zhao, and J. H. Pratt Improvement in Blood Pressure With Inhibition of the Epithelial Sodium Channel in Blacks With Hypertension Hypertension, September 1, 2005; 46(3): 481 - 487. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Meneton, X. Jeunemaitre, H. E. de Wardener, and G. A. Macgregor Links Between Dietary Salt Intake, Renal Salt Handling, Blood Pressure, and Cardiovascular Diseases Physiol Rev, April 1, 2005; 85(2): 679 - 715. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. A. Young, W. J. Katon, M. Von Korff, G. E. Simon, E. H. B. Lin, P. S. Ciechanowski, T. Bush, M. Oliver, E. J. Ludman, and E. J. Boyko Racial and Ethnic Differences in Microalbuminuria Prevalence in a Diabetes Population: The Pathways Study J. Am. Soc. Nephrol., January 1, 2005; 16(1): 219 - 228. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. F. Samaha, R. C. Rubenstein, W. Yan, M. Ramkumar, D. I. Levy, Y. J. Ahn, S. Sheng, and T. R. Kleyman Functional Polymorphism in the Carboxyl Terminus of the {alpha}-Subunit of the Human Epithelial Sodium Channel J. Biol. Chem., June 4, 2004; 279(23): 23900 - 23907. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Yan, F. F. Samaha, M. Ramkumar, T. R. Kleyman, and R. C. Rubenstein Cystic Fibrosis Transmembrane Conductance Regulator Differentially Regulates Human and Mouse Epithelial Sodium Channels in Xenopus Oocytes J. Biol. Chem., May 28, 2004; 279(22): 23183 - 23192. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Yang, S. Kupershmidt, and D. M. Roden Cloning and initial characterization of the human cardiac sodium channel (SCN5A) promoter Cardiovasc Res, January 1, 2004; 61(1): 56 - 65. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. H. Pratt, W. T. Ambrosius, R. Agarwal, G. J. Eckert, and S. Newman Racial Difference in the Activity of the Amiloride-Sensitive Epithelial Sodium Channel Hypertension, December 1, 2002; 40(6): 903 - 908. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-Z. Xue, O. Bonny, S. Morgenthaler, M. Bochud, V. Mooser, W. G. Thilly, L. Schild, and P.-M. Leong-Morgenthaler Use of Constant Denaturant Capillary Electrophoresis of Pooled Blood Samples to Identify Single-Nucleotide Polymorphisms in the Genes (Scnn1a and Scnn1b) Encoding the {alpha} and {beta} Subunits of the Epithelial Sodium Channel Clin. Chem., May 1, 2002; 48(5): 718 - 728. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. M. Snyder The Epithelial Na+ Channel: Cell Surface Insertion and Retrieval in Na+ Homeostasis and Hypertension Endocr. Rev., April 1, 2002; 23(2): 258 - 275. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. H. Pratt, G. J. Eckert, S. Newman, and W. T. Ambrosius Blood Pressure Responses to Small Doses of Amiloride and Spironolactone in Normotensive Subjects Hypertension, November 1, 2001; 38(5): 1124 - 1129. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. S. Pachori, M. J. Huentelman, S. C. Francis, C. H. Gelband, M. J. Katovich, and M. K. Raizada The Future of Hypertension Therapy: Sense, Antisense, or Nonsense? Hypertension, February 1, 2001; 37(2): 357 - 364. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. P. Thomas, R. W. Loftus, K. Z. Liu, and O. A. Itani Genomic organization of the 5' end of human beta -ENaC and preliminary characterization of its promoter Am J Physiol Renal Physiol, May 1, 2002; 282(5): F898 - F909. [Abstract] [Full Text] [PDF] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1999 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |